Qube Research & Technologies (QRT)’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
TAF
FDCDDQ
CWG
OIA
SC
Qube Research & Technologies (QRT)'s BTAL Position: Q3 2024 in Review
Qube Research & Technologies (QRT) sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2024, closing a stake of 7,825 shares — an estimated $154K sold.
Qube Research & Technologies (QRT) first reported a position in BTAL in Q3 2023 and held it in 4 quarters. The position peaked at $154K in Q2 2024. 71 funds tracked by Wall St. Rank hold BTAL as of Q3 2024.
- Qube Research & Technologies (QRT) reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q3 2024 after selling out during the quarter.
- Qube Research & Technologies (QRT) sold 7,825 AGF US Market Neutral Anti-Beta Fund shares in Q3 2024, an estimated $154K.
- Qube Research & Technologies (QRT) first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2023 and held it in 4 quarters.
- Qube Research & Technologies (QRT)'s AGF US Market Neutral Anti-Beta Fund position peaked at $154K in Q2 2024.
- 71 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2024.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.